v3.26.1
Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Accelerated Share Repurchase Agreements
The terms of each ASR agreement entered into during the six months ended June 30, 2026 and 2025, structured as outlined above, are as follows:
(in millions, except average price paid per share)
ASR Agreement Initiation DateASR Agreement Completion DateInitial Shares DeliveredAdditional Shares DeliveredTotal Number of Shares
Purchased		Average Price Paid Per ShareTotal Cash Utilized
May 7, 2026 1
June 10, 20260.90.3 1.2$414.76 $500 
February 12, 2026 2
March 12, 20262.00.3 2.3$426.70 $1,000 
May 6, 2025 3
August 8, 20251.00.2 1.2$518.47 $650 
February 19, 2025 4
May 6, 20251.00.3 1.3$491.12 $650 
1 The ASR agreement was structured as an uncapped ASR agreement in which we paid $500 million and initially received shares valued at 80% of the $500 million at a price equal to the market price of the Company’s common stock on May 7, 2026. The Company received an initial delivery of 0.9 million shares from the ASR program. We completed the ASR agreement on June 10, 2026 and received an additional 0.3 million shares. The ASR agreement was executed under our 2025 Repurchase Program.
2 The ASR agreement was structured as an uncapped ASR agreement in which we paid $1 billion and initially received shares valued at 80% of the $1 billion at a price equal to the market price of the Company’s common stock on February 12, 2026. The Company received an initial delivery of 2.0 million shares from the ASR program. We completed the ASR agreement on March 12, 2026 and received an additional 0.3 million shares. The ASR agreement was executed under our 2025 and 2022 Repurchase Programs.
3 The ASR agreement was structured as an uncapped ASR agreement in which we paid $650 million and initially received shares valued at 80% of the $650 million at a price equal to the market price of the Company’s common stock on May 6, 2025. The Company received an initial delivery of 1.0 million shares from the ASR program. We completed the ASR agreement on August 8, 2025 and received an additional 0.2 million shares. The ASR agreement was executed under our 2022 Repurchase Program.
4 The ASR agreement was structured as an uncapped ASR agreement in which we paid $650 million and initially received shares valued at 80% of the $650 million at a price equal to the market price of the Company’s common stock on February 19, 2025. The Company received an initial delivery of 1.0 million shares from the ASR program. We completed the ASR agreement on May 6, 2025 and received an additional 0.3 million shares. The ASR agreement was executed under our 2022 Repurchase Program.
Schedule of Redeemable Noncontrolling Interests
Changes to redeemable noncontrolling interests during the six months ended June 30, 2026 were as follows:
(in millions)
Balance as of December 31, 2025
$4,917 
Net income attributable to redeemable noncontrolling interests197 
Distributions payable to redeemable noncontrolling interests(165)
Redemption value adjustment86 
Other 1
(11)
Balance as of June 30, 2026 2
$5,024 
1 Includes foreign currency translation adjustments.
2 As of June 30, 2026, $5,022 million relates to our redeemable noncontrolling interest in the Indices business.
Schedule of Changes in the Components of Accumulated Other Comprehensive Loss
The following table summarizes the changes in the components of accumulated other comprehensive loss for the six months ended June 30:
(in millions)Foreign Currency Translation AdjustmentsPension and Postretirement Benefit PlansUnrealized Gain (Loss) on Cash Flow HedgesAccumulated Other Comprehensive Loss
Balance as of December 31, 2025
$(403)$(386)$92 $(697)
Other comprehensive income (loss) before reclassifications(75)1(4)(7)(86)
Reclassifications from accumulated other comprehensive income (loss) to net earnings
2 6 23 311 
Net other comprehensive income (73)2 (4)(75)
Balance as of June 30, 2026
$(476)$(384)$88 $(772)
1Includes an unrealized gain related to our cross currency swaps. See Note 5 – Derivative Instruments for additional detail of items recognized in accumulated other comprehensive loss.
2Reflects amortization of net actuarial losses and is net of a tax expense of $1 million for the six months ended June 30, 2026. See Note 6 — Employee Benefits for additional details of items reclassed from accumulated other comprehensive loss to net earnings.
3See Note 5 — Derivative Instruments for additional details of items reclassified from accumulated other comprehensive loss to net earnings.